VD

Vaishali Dnyaneshwar Patil

Active Director Director DIN 08066545
DIN 08066545 First appointment Feb 2018 Primary industry Veterinary
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About Vaishali Dnyaneshwar Patil

Data last updated:

Vaishali Dnyaneshwar Patil is a Director at Dvns Healthcare Private Limited (since 2018). The company operates in Veterinary.

DIN 08066545
Primary Designation Director
Industry Veterinary
First Appointment 08 Feb 2018
Oldest Company Age 8 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Dvns Healthcare Private Limited U85200MH2018PTC304918
Director08 Feb 20182018Active

Board colleagues of Vaishali Dnyaneshwar Patil

NameDINCompanyDesignation
Dnyaneshwar Arjun Patil08066544Dvns Healthcare Private LimitedDirector

Directorship timeline

Open interactive timeline →
Dvns Healthcare Private Limited
Premium access

Shareholding and investment profile for Vaishali Dnyaneshwar Patil

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vaishali Dnyaneshwar Patil

Vaishali Dnyaneshwar Patil currently holds 1 directorship: Dvns Healthcare Private Limited (Director, since 08 Feb 2018).

Vaishali Dnyaneshwar Patil was first appointed on 08 Feb 2018 as Director at Dvns Healthcare Private Limited.

The current boards of Vaishali Dnyaneshwar Patil's companies include Dnyaneshwar Arjun Patil (Dvns Healthcare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available